The Current Ratio of Keros Therapeutics Inc (KROS) is 21.45.
Current Ratio compares a firm's current assets to its current liabilities to assess short-term liquidity. A ratio above 1.0 typically indicates a strong ability to meet obligations.
| Date | Value |
|---|---|
| 2024-12-31 | 21.45 |
| 2023-12-31 | 14.25 |
| 2022-12-31 | 17.32 |
| 2021-12-31 | 21.31 |
| 2020-12-31 | 37.18 |
| 2019-12-31 | 1.98 |
| 2018-12-31 | 2.22 |